Clinical Trials Logo

Filter by:
NCT ID: NCT00254891 Terminated - Clinical trials for Carcinoma, Non-Small-Cell Lung

Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer

Start date: November 2005
Phase: Phase 3
Study type: Interventional

To assess the efficacy and safety of PF-3512676 administered in combination with paclitaxel/carboplatin chemotherapy as first-line treatment in patients with locally advanced or metastatic Non-Small-Cell Lung Cancer (NSCLC) and to compare it to the efficacy and safety of paclitaxel

NCT ID: NCT00208390 Terminated - Clinical trials for Rheumatoid Arthritis

A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement

Start date: February 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to monitor the performance of the Summit™ hip in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

NCT ID: NCT00165009 Terminated - Clinical trials for Peptic Ulcer Hemorrhage

Resolution Endoclips Vs Epinephrine Injection and Heater Probe

Start date: June 2005
Phase: Phase 3
Study type: Interventional

To compare the efficacy of a novel endoscopic clipping device(Resolution Clip™) and conventional epinephrine injection and heater probe thermocoagulation in control of peptic ulcer bleeding and prevention of recurrent bleeding

NCT ID: NCT00164905 Terminated - Clinical trials for Peptic Ulcer Hemorrhage

Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage

Start date: September 2004
Phase: N/A
Study type: Interventional

The aim of study is to evaluate whether Doppler ultrasound can accurately identify patients who are at risk of recurrent bleeding, who will require endoscopic therapy, and who will fail endoscopic therapy.

NCT ID: NCT00164814 Terminated - Clinical trials for Non-Cardiac Chest Pain

The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients

Start date: n/a
Phase: N/A
Study type: Observational

Noncardiac chest pain (NCCP) is a common clinical problem worldwide. In Hong Kong, it has been estimated that about 20% of patients with chest pain are misdiagnosed to have coronary heart disease. Despite its benign nature, this condition causes anxiety, impairs quality of life and consumes a substantial amount of healthcare resources. While acid reflux and motility disorder in the esophagus are often attributed as the cause of NCCP, visceral hyperalgesia of esophagus is now recognized to play a central role in the pathogenesis of this condition. This research project aims to evaluate the role of visceral hyperalgesia in Chinese patients with NCCP. NCCP patients will be evaluated for the prevalence of gastroesophageal reflux disease and esophageal motility disorder by endoscopy, manometry and pH study. The visceral sensory and pain thresholds of these patients will be compared with asymptomatic controls.

NCT ID: NCT00164801 Terminated - Clinical trials for Non-Cardiac Chest Pain

Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese?

Start date: November 2004
Phase: N/A
Study type: Interventional

The effect of baclofen (GABAB agonist), diltiazem (muscle relaxant) and placebo will be compared in a double-blinded randomized study for the treatment of NCCP. Cerebral cortical, brainstem and spinal evoked potentials before and after treatment will be evaluated. Results of this study will shed lights on pathogenesis and treatment of NCCP in Chinese.We hypothesize that Baclofen alleviates visceral hyperalgesia in NCCP patients by suppressing afferent sensory pathway.

NCT ID: NCT00164788 Terminated - Clinical trials for Gastrointestinal Hemorrhage

A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole

Start date: July 2004
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that high dose esomeprazole 80mg given as a bolus, followed by 8mg/h would render gastric pH near neutral and that pH control with esomeprazole given in such a high dose either intravenous or orally is identical.

NCT ID: NCT00125437 Terminated - Clinical trials for Heart Failure, Congestive

Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy

Start date: September 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a larger dose of the aldosterone antagonist spironolactone combined with a lower dose of an ACE inhibitor is more effective in reverse left ventricular remodeling in severe congestive heart failure in patients with nonischemic cardiomyopathy.

NCT ID: NCT00057382 Terminated - Clinical trials for Hepatocellular Carcinoma

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Start date: March 2003
Phase: Phase 2/Phase 3
Study type: Interventional

This is an international, multicenter, randomized study of intravenous T138067 versus intravenous doxorubicin in hepatocellular carcinoma (liver cancer). Patients can not have been treated before with chemotherapy and surgery is not recommended for their cancer. A total of 750 subjects will be enrolled in this study.

NCT ID: NCT00040144 Terminated - Chronic Hepatitis B Clinical Trials

Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

Start date: July 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study was to determine the safety and antiviral hepatitis B virus (HBV) activity of ACH126, 433 in the treatment of adults with lamivudine-resistant chronic hepatitis B.